Drinker Biddle & Reath LLP
Biomarkers for cholangiocellular carcinoma (CCC)
The invention relates to a method for identifying specific marker proteins (biomarkers) for cholangiocellular carcinoma (CCC), the biomarkers for CCC identified by the method and the use thereof, in particular for diagnosis, surveillance and treatment. The invention further relates to a diagnostic device comprising the biomarkers for CCC and a screening assay wherein these biomarkers for CCC are used to identify novel pharmaceutical compounds for treatment of CCC.
LEIBNIZ-INSTITUT FÜR ANALYTISCHE WISSENSCHAFTEN—ISAS—E.V.
G G G G G G G
G01N G01N G01N G01N G01N G01N G01N
inventional additional inventional inventional additional additional additional
Dominik Juliet Frank Hideo A. Barbara Helmut E. Thilo Jörg F.
Megger Padden Weber Baba Sitek Meyer Bracht Schlaak